title: Systemic lupus erythematosus presenting with myelofibrosis.
abstract: The 20-year-old girl we describe presented with myelofibrosis and systemic lupus erythematosus (SLE), which initially responded to treatment with corticosteroids but during a relapse 9 months later a bone marrow biopsy revealed no improvement in her myelofibrosis. As the cytotoxic treatments used to treat severe SLE may be associated with bone marrow suppression, it is important to consider the possibility of myelofibrosis complicating SLE, which, even when it is a presenting feature, may not readily respond to corticosteroids. When this girl was subsequently treated with high dose steroid and azathioprine her myelofibrosis went into remission.
authors.affiliation: St. James's University Hospital, Leeds, UK.
authors.forename: D
authors.initials: D
authors.lastname: Foley-Nolan
authors.forename: M F
authors.initials: MF
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: Rowbotham
authors.forename: A
authors.initials: A
authors.lastname: McVerry
authors.forename: H C
authors.initials: HC
authors.lastname: Gooi
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000305:Adrenal Cortex Hormones; D001379:Azathioprine